- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02724930
Cooperative Pain Education and Self-management (COPES)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cognitive behavioral therapy (CBT) for chronic pain is a commonly used evidence-based self-management intervention. Though effective, CBT requires that patients attend multiple in-person visits and that highly trained staff be available to provide care. For these reasons CBT is resource intensive, often inaccessible to Veterans, and delivered unevenly across patients and facilities. In a Veterans Health Administration Office of Health Services Research and Development (HSR&D) IIR-funded trial, investigators found that CBT delivered primarily via an automated Interactive Voice Response (IVR) system (Cooperative Pain Education and Self-management or COPES) leads to patient-centered outcomes that are comparable to standard United States Department of Veterans Affairs (VA) approaches in which CBT is delivered in-person by a therapist over ten weekly sessions. In this study, implementation facilitation will be guided by the Consolidated Framework for Implementation Research (CFIR) which provides a set of constructs to identify potential barriers and facilitators to implementation. The primary objective of this project is to evaluate the effectiveness of the facilitation approach paired with automated case finding and direct patient outreach on uptake of COPES in the clinical care setting. Study investigators will specifically target Veterans who receive care at community-based outpatient clinics (CBOCs) because these sites typically have few or no therapists trained in CBT for chronic pain.
Description of COPES: COPES is a 10-week, IVR-facilitated program of CBT for chronic pain. The primary components of COPES include: 1) a self-help handbook to teach Veterans pain self-management skills and describe the weekly skill practice goals, 2) a pedometer-facilitated progressive walking program (all COPES patients will be given an Omron Go Smart, Model HJ-112 pocket pedometer at the time of enrollment), and 3) daily, automated IVR calls to collect patient-reported pain intensity and pain-related interference, sleep quality, pedometer-measured step count, and adherence to the pain coping skill practice ratings. Participants will also receive a weekly, two to four minute pre-recorded, personalized therapist message via the IVR system based on the participant's IVR-recorded data. Therapists provide feedback on the participant's weekly average pain intensity, sleep, steps, and pain coping skill practice, note any changes from the prior week, and comment on symptom or activity patterns. Therapists also provide reinforcement for goal accomplishment, help patients make connections among pain, pain coping skill practice, and goal accomplishment, and assign a steps and skill practice goal for the upcoming week.
Research Design: Study investigators will test the effectiveness of the facilitation approach to implement COPES as a means to remotely deliver in-home self-management support to Veterans with chronic pain. To evaluate the implementation's success, study investigators will conduct a multi-site, stepped wedge, Hybrid III trial in 17 CBOCs affiliated with three geographically dispersed sites (VA Boston, VA Palo Alto, and Roudebush VA in Indianapolis). Clusters (k=17 CBOCs) will be randomized to 6 different time periods proportional to approximate eligible patient population size. Each CBOC will serve as its own control for a period of time before "transitioning" into enhanced facilitation; the time of this transition is randomized in a stepped fashion. The primary outcome for evaluating implementation success will be patient enrollment in COPES. The secondary outcome will be provider referral. Other outcomes that will be investigated as part of the nested COPES effectiveness study will be Veterans' physical functioning, pain intensity, and physical activity.
Methodology: Study investigators will evaluate the success of the implementation strategy by evaluating the proportion of patients who are offered enrollment in COPES who actually enroll. Additionally, study investigators will conduct a formative evaluation to inform, refine and evaluate implementation of COPES. The evaluation will include interviews with VA staff and patients with chronic back pain at the proposed implementation sites. Interview guides will be based on CFIR model constructs using questions adapted from the CFIR interview guide. Investigators will also measure pre-post differences in pain-relevant outcomes (pain intensity, physical functioning and physical activity).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Menlo Park, California, United States, 94025
- VA Palo Alto Healthcare System
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Richard L. Roudebush VA Medical Center
-
-
Massachusetts
-
Brockton, Massachusetts, United States, 02301
- VA Boston Healthcare System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Veterans COPES:
- Back-pain-related International Classification of Diseases (ICD)-9 diagnosis
- Pain intensity rating of ≥4 (indicating moderate pain) on the 0-10 Numerical Rating Scale on at least two separate outpatient encounters at a CBOC in the prior year
- CBOC patient at VA Boston, VA Palo Alto or Roudebush VA
Veterans Interviews:
- Those who are eligible for COPES, but who have not been asked to enroll (pre-implementation period)
- Those who participate in COPES (post-implementation)
- Those who decline enrollment in COPES (post-implementation)
- CBOC patients at VA Boston, VA Palo Alto or Roudebush VA
Admin, Champion, Provider Interviews:
1. Employed at the project implementation sites
Exclusion Criteria:
Veterans (COPES & Interviews):
- Diagnosis of cancer, dementia, schizophrenia, and active alcohol or substance abuse
- Psychiatric hospitalization in the past 30 days
- Patients who are designated as fall risks and/or have active diabetic foot ulcers
Admin, Champion, Provider Interviews:
1. Not employed at the project implementation sites
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard Implementation
Standard COPES implementation consists of provider education including brief in-person presentations and written material.
|
|
|
Experimental: Implementation Facilitation
Enhanced facilitation of COPES implementation. All clusters start in the standard implementation group and cross-over from the control group to the intervention group in a randomized stepped-wedge fashion at 7 time points over the course of the 33 week implementation. |
Enhanced facilitation of COPES implementation consists of promotional meetings, automated case finding and proactive outreach to recruit patients, marketing and educational materials, local champion, and academic detailing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient enrollment
Time Frame: Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Patient enrollment measured as the probability an eligible patient enrolls in Cooperative Pain Education and Self-management (COPES).
|
Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Provider referrals
Time Frame: Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Provider referrals to COPES measured as the total number of provider referrals and the number of referrals per provider by: site, time point, and overall.
|
Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain-related interference
Time Frame: Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Pain-related interference will be assessed using the interference items of the "PEG 3 A Three-Item Scale Assessing Pain Intensity and Interference" (PEG-3) which assesses interference with general activity and enjoyment of life.
|
Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
|
Pain intensity
Time Frame: Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Pain intensity will be assessed using the pain intensity question of the PEG-3.
|
Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
|
Physical activity
Time Frame: Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Physical activity will be assessed by pedometer-measured step count.
|
Baseline, 6 months post-facilitation, and study end (up to 30 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alicia A Heapy, PhD, VA Connecticut Healthcare System
- Principal Investigator: John D Piette, PhD, VA Ann Arbor Healthcare System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Kansas Medical CenterCompletedLower Back Pain | Low Back Pain | Low Back Pain, Mechanical | Low Back Pain, Recurrent | Low Back Pain, Postural | Postural Low Back Pain | Mechanical Low Back Pain | Low Back Ache | Recurrent Low Back Pain | Lower Back Pain Chronic | Low Back Pain, Posterior Compartment | Low BackacheUnited States
-
Kirsehir Ahi Evran UniversitesiHacettepe University; Selcuk UniversityRecruitingLow Back Pain, Mechanical | Non Specific Chronic Low Back Pain | Low Back Pain, ChronicTurkey
-
University of BarcelonaHospital Clinic of BarcelonaRecruitingBack Pain | Chronic Low-back Pain | Chronic Low-back Pain (cLBP)Spain
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
Xijing HospitalRecruitingLow Back Pain | Non-specific Chronic Low Back Pain | CLBP - Chronic Low Back Pain | Paraspinal MuscleChina
-
University of FaisalabadNot yet recruiting
-
Marmara UniversityCompletedMechanical Low Back Pain | Chronic Low Back Pain (CLBP)Turkey
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Rhode Island HospitalRecruitingChronic Pain | Chronic Low-back PainUnited States
Clinical Trials on Enhanced facilitation of COPES
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA); Texas Christian University; Columbia... and other collaboratorsCompletedSubstance Use DisordersUnited States
-
VA Office of Research and DevelopmentRecruitingSuicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of Alabama at BirminghamCompleted
-
Stanford UniversityNational Institute on Drug Abuse (NIDA); University of Wisconsin, Madison; Washington...Active, not recruitingAddiction, OpioidUnited States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSuicide | Alcohol Use DisorderUnited States
-
Asir John SamuelUnknownNeonatal Respiratory Distress SyndromeIndia
-
Yeditepe UniversityBahçeşehir UniversityCompleted
-
Henry Ford Health SystemNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingLiver Diseases | Alcohol-related Liver DiseaseUnited States
-
University of California, DavisNational Institute on Aging (NIA); Alzheimer's AssociationCompletedCognitive Impairment | Alzheimer's Disease (Incl Subtypes)United States